"The Value and Pricing of Innovative Medicines" - Virtual Launch
All patients in the EU have a right to access high-quality, patient-centred care in a timely manner. Medicines form one of the most important aspects of treatment for many patients. However, there are concerns in Europe and globally that the cost of some new medicines is undermining health systems’ capacity to provide sustainable and equitable access for all. Patients will only benefit from new, innovative therapies if they are available in a timely manner, accessible and affordable to all who need them.
In the context of current political priorities and goals to ensure access to affordable medicines and review Europe’s pharmaceutical strategy a forthcoming new Pharmaceutical Strategy for Europe, EPF will be publishing and presenting its new position paper entitled ‘The Value and Pricing of Innovative Medicines’, during an event which will take place virtually on 1 July from 15h-17h.
Our paper contributes EPF’s perspective as a cross-disease umbrella patient organisation to the EU-level and international debate on prices and value of innovative medicines, building on our core principles of 2016.
The event will be moderated by EPF President Marco Greco and co-hosted by MEPs Kateřina Konečná, Tomislav Sokol and Tiemo Wölken. Reactions from a panel of prestigious speakers will follow the presentation of EPF’s paper and the event will close with a keynote speech by EU Commissioner for Health and Food Safety, Stella Kyriakides.
The Position Paper, Executive Summary as well as the link to join the virtual event will be circulated to registered participants on 30 June.
Follow along on Twitter: EPF will be live-tweeting during the virtual launch and ask that participants follow along and address any questions or comments you may to our handle @eupatientsforum using the hashtag #AccessForPatients.
Take a look at our draft agenda for more information.